MAP microba life sciences limited

This looks like another stupid move.The research business is...

  1. 10,123 Posts.
    lightbulb Created with Sketch. 1041
    This looks like another stupid move.

    The research business is cashflow breakeven.
    The point of selling it is not clear to me.
    I would have thought the research business is the platform for future discoveries/products.

    I guess the bankers on the Board thought they needed to do something.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.2¢
Change
-0.004(4.17%)
Mkt cap ! $47.38M
Open High Low Value Volume
9.6¢ 9.6¢ 9.2¢ $11.09K 118.8K

Buyers (Bids)

No. Vol. Price($)
5 20774 9.2¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 114482 1
View Market Depth
Last trade - 15.11pm 29/07/2025 (20 minute delay) ?
MAP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.